Company intelligence / Profile preview
Phoenix Nest Inc.
Brooklyn, New York, United Statesphoenixnestbiotech.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
The company is developing treatments for Sanfilippo syndrome, an ultra-rare genetic disorder. They have received Small Business Innovation Research grants from NIH to facilitate research in academic labs and have licensed these programs. Currently, they have drugs in preclinical and discovery stages.
- Therapeutic areas
- Rare Diseases
- Modalities
- Recombinant polypeptideAAV-based gene therapyEnzyme
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Collaborations with leading academics
Beyond the preview
Go deeper on Phoenix Nest Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phoenix Nest Inc..